Nuchal translucency (NT) refers to an ultrasound measurement of the back of the fetal neck, which can be done from approximately 11 through 13 weeks of pregnancy. First-trimester screening combines the NT measurement with the results of a blood test, your age, and your ethnic background.
From these factors, a personal risk estimate is calculated. A positive result will identify 85% of Down syndrome cases and 80% of Trisomy 18 cases. In other words, if your fetus has Down syndrome, there is an 85% chance that the test will identify it. Likewise, if your fetus has Trisomy 18, there is an 80% chance the test will be positive for Trisomy 18. This test is a screen; in other words, it does not tell you definitively whether there is a fetal abnormality.
It simply determines the chances that your fetus has Down syndrome or Trisomy 18, and reveals whether those risks are high or low. The results are usually complete within 1 week. An abnormal first-trimester screen allows you to consider the option of the first-trimester diagnostic test, CVS (see later).
Saturday, May 18, 2013 at the New York State Fairgrounds and Expo Center in Syracuse, NY. The Susan G. Komen Race for the Cure® Series, is the largest series of 5K runs/fitness walks in the world. It raises significant funds and awareness for the fight against breast cancer, celebrates breast cancer survivorship and honors thoseRead more →
Detecting Breast Cancer with 3D Technology Breast cancer is the most common cancer among women, except for skin cancer, and it is the second leading cause of cancer death in women, after lung cancer. Regular screening examinations enable early detection of breast cancer, which leads to a significant increase in the chance of recovery. 3DRead more →